| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2745 | |||||||||||||||||||||||
| Submitter : | Mrs. Rose Ann Feldpausch | Date & Time: | 12/07/2006 11:12:10 | |||||||||||||||||||||
| Organization : | Mrs. Rose Ann Feldpausch | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I would like to recommend to all vacinne producers that I find it impossible to see the necessity of using any type of fetal cell lines as from the research that I have done I find there are many available lines which do not use fetal cells that work just as effectively and don't kill a human in doing so.
Sincerely, Rose Ann Feldpausch | ||||||||||||||||||||||||